Certara Inc Ordinary Shares CERT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
-
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Trading Information
- Previous Close Price
- $8.96
- Day Range
- $8.58–8.96
- 52-Week Range
- $4.45–13.30
- Bid/Ask
- $8.51 / $8.68
- Shares Outstanding
- 152.54M
- Market Cap
- $1.32B
- Volume/Avg
- 4M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 22.42
- Price/Sales
- 3.58
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 5.49%
Company Profile
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,576
- Website
- https://www.certara.com
Valuation
|
Metric
|
CERT
|
|---|---|
Price/Earnings (Normalized) | 22.42 |
Price/Book Value | 1.41 |
Price/Sales | 3.58 |
Price/Cash Flow | 18.90 |
Price/Earnings
CERT
Financial Strength
|
Metric
|
CERT
|
|---|---|
Quick Ratio | 2.43 |
Current Ratio | 2.55 |
Interest Coverage | 0.03 |
Quick Ratio
CERT
Profitability
|
Metric
|
CERT
|
|---|---|
Return on Assets (Normalized) | 3.89% |
Return on Equity (Normalized) | 5.66% |
Return on Invested Capital (Normalized) | 5.57% |
Return on Assets
CERT
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|rc@dkkb | LOCK|!? | $46B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|$L | $13B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|MJ&S# | $13B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|#c<D | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|t>$T | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|<h@h^ | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|&@%s | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|<@&! | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|Ly$g | $8B | |||
| Waystar Holding Corp
WAY
| — | LOCK|!?R | $5B |
United States